Corey Williams
Corey Williams's Latest Posts
SET Monthly Issue August 2013
August 2013 GET BLOWN AWAY BY THIS AMAZING OPPORTUNITY! August has been an interesting month so far… Just a few weeks ago, the S&P 500 hit an all-time high of 1,709. Since then, the large cap index has fallen 3.7%. Admittedly, a pullback of less than 5% isn’t much to get excited about. These types […]
BST Trade Alert: August 14, 2013
August 14, 2013 Recommendation: Buy GTx (NASDAQ: GTXI) up to $4.75 per share. About the Company: GTx is an exciting biotech with huge upside potential. They’re developing drugs for the treatment of cancer, cancer supportive care, and other serious medical conditions. What I find fascinating about this company is that it’s pioneering a new field in the […]
SET Portfolio Update August 2013
August 6, 2013 Dear Sector ETF Trader Reader, It’s August and I’m sweating it out in the summer heat here in Scottsdale. I know it’s a “dry heat” but 110 degrees still feels like an oven. But that’s nothing compared to how hot the stock market is right now. It seems like stocks will continue […]
BST Position Update: August 6, 2013
August 6, 2013 . . . . ImmunoCellular Therapeutics (NYSE: IMUC) – Hold Our latest recommendation is off to a very fast start. After hitting a new intra-day high of $3.69 today, IMUC finished the day at $3.57 to give us a solid 28% gain on the position. Not bad for just eight trading days in the […]
BST Trade Alert: July 25, 2013
July 25, 2013 Recommendation: Buy ImmunoCellular Therapeutics (NYSE: IMUC) up to $3.05 per share. About the Company: ImmunoCellular is an exciting biotech operating on the cutting edge of science and medicine. They’re developing immune-based therapies to treat brain cancer, ovarian cancer, and other solid tumors. Here’s a quick overview of how immunotherapy is designed to work… Our […]
SET Monthly Issue July 2013
July 2013 PROFIT FROM RISING INTEREST RATES Interest rates are soaring in the wake of Fed Chairman Bernanke’s ‘tapering’ talk. In fact, the yield on the benchmark ten-year Treasury is at the highest level in nearly two years. As I pointed out last month, if the Fed wanted to keep long term interest rates low, […]
SET Portfolio Update July 2013
July 2, 2013 Dear Sector ETF Trader Reader, I’ll admit it, I was dead wrong about Fed Chairman Bernanke’s comments after the FOMC meeting a few weeks ago. The day before the FOMC meeting I said, “The world needs the US to keep interest rates low. And the only way Bernanke can reassure investors that […]
BST Position Update: July 2, 2013
July 2, 2013 . . . . Halozyme Therapeutics (NASDAQ: HALO) – Hold HALO’s surging! Since hitting a low of $5.88 on June 24th, the biotech has climbed 34% to $7.88! And today it traded over $8.30 for the first time since mid-May. The stock’s jumping on good news for Herceptin SC. Herceptin SC is […]
SET Monthly Issue June 2013
June 2013 TO TAPER OR NOT TO TAPER? THAT IS THE QUESTION Over the last month, global financial markets have been embroiled in speculation about the Federal Reserve. More specifically, investors want to know when the Fed will make a change to their current bond buying program. Up until May 22nd, the general consensus was […]
BST Position Update: June 18, 2013
June 18, 2013 . . . . Rockwell Medical (NASDAQ: RMTI) – Buy up to $4.40 RMTI is our most recent biotech recommendation. They’re developing Soluble Ferric Phosphate (SFP) for iron therapy treatment in patients with chronic kidney disease. Rockwell believes SFP will provide significant improvement over current IV iron therapy for dialysis patients. Unlike […]
